AstraZeneca Pharma Ind Ltd. (ASTRAZEN)

Volume: 735Avg Vol 1W: 1,141Avg Vol 1M: 3,10452W Range:₹7,551.5₹10,691

NSE BSE www.astrazeneca.in

₹8,512.5▲ 0.11%

Key Ratios

Updated 3h ago

Market Cap—

Current Price₹8,512.5

Previous Close₹8,503

High / Low (52w)₹10,691 / ₹7,551.5

Volume735

Avg Vol (1W)1,141

Avg Vol (1M)3,104

Stock P/E—

Book Value₹349.12

Dividend Yield—

ROE—

ROA—

Revenue (TTM)₹2,276 Cr

Revenue Growth—

Profit Margin—

Total Debt—

Shares Outstanding—

Face Value₹2

EPS (TTM)₹17.95

P/B24.35

Debt / Equity—

50 DMA₹8,535.15

200 DMA₹8,496.13

Day change+0.11%

Price Chart

₹8,512.5▼ 8.91% · 1Y

2025-10-20

2026-06-16

20-day avg volume: 3K shares

Pros

Revenue grew 32% YoY.

Quarterly Results

Metric	Mar 2026	Dec 2025	Sept 2025	Jun 2025	Mar 2025	Dec 2024	Sept 2024	Jun 2024	Mar 2024	Dec 2023	Sept 2023	Jun 2023	Mar 2023	Dec 2022	Sept 2022	Jun 2022	Mar 2022	Dec 2021	Sept 2021	Jun 2021	Mar 2021	Dec 2020	Sept 2020	Jun 2020	Mar 2020
Revenue	₹579 Cr	₹612 Cr	₹559 Cr	₹526 Cr	₹480 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
EBITDA	₹55 Cr	₹41 Cr	₹73 Cr	₹65 Cr	₹69 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Net Profit	₹45 Cr	₹33 Cr	₹54 Cr	₹56 Cr	₹58 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
EPS	17.95	13.04	21.69	22.33	23.3	12.34	16.37	-4.72	15.79	6.32	20.95	21.54	6.91	11.72	13.03	8.06	11.19	4.57	4.78	4.1	10.91	8.42	10.54	7.45	3.83

Profit & Loss (Annual)

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2011	Mar 1999
Revenue	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹832 Cr	₹728 Cr	₹574 Cr	₹101 Cr
EBITDA	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Net Profit	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
EPS	46.3	64.6	39.7	24.6	37.3	—	—	—	—

Balance Sheet

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Total Assets	₹1,989 Cr	₹1,518 Cr	₹1,078 Cr	₹985 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Total Liabilities	₹1,116 Cr	₹748 Cr	₹366 Cr	₹396 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Equity	₹873 Cr	₹770 Cr	₹712 Cr	₹589 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Total Debt	₹111 Cr	₹36 Cr	₹5 Cr	₹7 Cr	₹0 Cr	₹0 Cr	₹0 Cr

Cash Flow

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Operating	₹-15 Cr	₹65 Cr	₹28 Cr	₹58 Cr	₹0 Cr	₹0 Cr
Investing	₹19 Cr	₹31 Cr	₹22 Cr	₹18 Cr	₹0 Cr	₹0 Cr
Financing	₹-92 Cr	₹-66 Cr	₹-44 Cr	₹-24 Cr	₹0 Cr	₹0 Cr
Free Cash Flow	₹-19 Cr	₹64 Cr	₹17 Cr	₹50 Cr	₹0 Cr	₹0 Cr

Shareholding

Promoter 75% Institutions 8.58% Public 16.42%

About AstraZeneca Pharma Ind Ltd.

Pharmaceuticals · Pharmaceuticals - Multinational

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cardiovascular, renal, metabolic, and immunological conditions; oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names. The company also offers medicines for diabetes; and clinical trial services. The company has a strategic collaboration with Leica Biosystems and Daiichi Sankyo Company, Limited for the development of an immunohistochemistry assay and an image analysis algorithm for the TROP2 NMR biomarker in non-small cell lung cancer. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search